Skip to content
healthcare.dev

Remodulin

NDC 66302-102, treprostinil, injection, solution, from United Therapeutics Corporation.

Product NDC
66302-102
Status
Listed
Labeler
United Therapeutics Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021272
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66302-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TREPROSTINIL50 mg/20mL

Pharmacologic classes

Prostacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE]

Package NDCNDC-11Package
66302-102-01663020102011 VIAL in 1 BOX (66302-102-01) / 20 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6c80bb38-e8db-4138-9f0d-dbbf9c673185
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=66302-102

Use it

Look up 66302-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66302-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66302-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.